Robotic Percutaneous Coronary Intervention in Coronary Heart Disease: Applications and Recent Advances

IF 0.9 4区 医学 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS Cardiovascular Innovations and Applications Pub Date : 2023-01-01 DOI:10.15212/cvia.2023.0062
Yan-Jun Song, Zechen Liu, Weihua Song, Dong Yin, Kefei Dou
{"title":"Robotic Percutaneous Coronary Intervention in Coronary Heart Disease: Applications and Recent Advances","authors":"Yan-Jun Song, Zechen Liu, Weihua Song, Dong Yin, Kefei Dou","doi":"10.15212/cvia.2023.0062","DOIUrl":null,"url":null,"abstract":"Traditional percutaneous coronary intervention (T-PCI) has long been an effective method for treating coronary heart disease (CHD), but the radiation hazards and orthopedic injuries among T-PCI operators are concerning. These problems have been mitigated with the emergence of robotic percutaneous coronary intervention (R-PCI), which is expected to increase intervention accuracy and safety. In this review, we first summarize the current status of PCI development, including robot systems, and PCI application and evaluation. Second, we compare T-PCI and R-PCI to identify the benefits for patients and physicians. In addition, we describe a new R-PCI system, R-PCI WSER-CD01, which incorporates multi-instrument collaborative delivery and provides full-process assistance in minimally invasive vascular intervention. This system introduces three key innovations that address safety concerns, and improve the accuracy, wire compatibility, and remote operation capabilities of existing of vascular intervention robot systems. Finally, we discuss prospects for the development of R-PCI. As an emerging technology, R-PCI aligns well with the trends of precision medicine and telemedicine, and therefore warrants continued innovation.","PeriodicalId":41559,"journal":{"name":"Cardiovascular Innovations and Applications","volume":"23 1","pages":"0"},"PeriodicalIF":0.9000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cardiovascular Innovations and Applications","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15212/cvia.2023.0062","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Traditional percutaneous coronary intervention (T-PCI) has long been an effective method for treating coronary heart disease (CHD), but the radiation hazards and orthopedic injuries among T-PCI operators are concerning. These problems have been mitigated with the emergence of robotic percutaneous coronary intervention (R-PCI), which is expected to increase intervention accuracy and safety. In this review, we first summarize the current status of PCI development, including robot systems, and PCI application and evaluation. Second, we compare T-PCI and R-PCI to identify the benefits for patients and physicians. In addition, we describe a new R-PCI system, R-PCI WSER-CD01, which incorporates multi-instrument collaborative delivery and provides full-process assistance in minimally invasive vascular intervention. This system introduces three key innovations that address safety concerns, and improve the accuracy, wire compatibility, and remote operation capabilities of existing of vascular intervention robot systems. Finally, we discuss prospects for the development of R-PCI. As an emerging technology, R-PCI aligns well with the trends of precision medicine and telemedicine, and therefore warrants continued innovation.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
机器人经皮冠状动脉介入治疗冠心病:应用和最新进展
传统经皮冠状动脉介入治疗(T-PCI)一直是治疗冠心病的有效方法,但其对患者的辐射危害和骨科损伤令人担忧。随着机器人经皮冠状动脉介入治疗(R-PCI)的出现,这些问题得到了缓解,这有望提高介入的准确性和安全性。在本文中,我们首先总结了PCI的发展现状,包括机器人系统,PCI的应用和评估。其次,我们比较了T-PCI和R-PCI,以确定患者和医生的益处。此外,我们描述了一种新的R-PCI系统,R-PCI WSER-CD01,它结合了多仪器协作交付,并提供微创血管介入的全过程协助。该系统引入了三个关键创新,解决了安全问题,提高了现有血管介入机器人系统的准确性、导线兼容性和远程操作能力。最后,对R-PCI的发展前景进行了展望。作为一项新兴技术,R-PCI符合精准医疗和远程医疗的发展趋势,因此值得持续创新。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Cardiovascular Innovations and Applications
Cardiovascular Innovations and Applications CARDIAC & CARDIOVASCULAR SYSTEMS-
CiteScore
0.80
自引率
20.00%
发文量
222
期刊最新文献
Mechanisms of Sodium-glucose Cotransporter 2 Inhibitors in Heart Failure Incidence, Predictors and Associations Between In-Hospital Bleeding and Adverse Events in Patients with Acute Coronary Syndrome Above 75 Years of Age – The Real-World Scenario Single-Cell RNA Sequencing Maps Immune Cell Heterogeneity in Mice with Allogeneic Cardiac Transplantation Coronavirus Disease 2019, Myocardial Injury, and Myocarditis Predictive Value of a Combination of the Age, Creatinine and Ejection Fraction (ACEF) Score and Fibrinogen Level in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1